The hormone resistin links obesity to diabetes
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is a chronic disease that leads to complications including heart disease, stroke, kidney failure, blindness and nerve damage. Type 2 diabetes, characterized by target-tissue resistance to insulin, is epidemic in industrialized societies and is strongly associated with obesity; however, the mechanism by which increased adiposity causes insulin resistance is unclear. Here we show that adipocytes secrete a unique signalling molecule, which we have named resistin (for resistance to insulin). Circulating resistin levels are decreased by the anti-diabetic drug rosiglitazone, and increased in diet-induced and genetic forms of obesity. Administration of anti-resistin antibody improves blood sugar and insulin action in mice with diet-induced obesity. Moreover, treatment of normal mice with recombinant resistin impairs glucose tolerance and insulin action. Insulin-stimulated glucose uptake by adipocytes is enhanced by neutralization of resistin and is reduced by resistin treatment. Resistin is thus a hormone that potentially links obesity to diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In rodents, resistin is predominantly secreted by adipose tissue, whereas in humans, it is primarily produced by immune cells, suggesting a potential species-specific functional divergence [9].”
From The Resistin/TLR4/miR-155-5p axis: a novel signaling pathway in the onset of hypothalamic neuroinflammation (2025) · cites this paper as [9]
In the citing paper
“The subcutaneous injection of estradiol benzoate reduces resistin levels in adipocytes [136].”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [136]
Citations
Cites
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites
Nielsen, H., Engelbrecht, J., Brunak, S., & von Heijne, G. (1997) · Protein Engineering Design and Selection · doi:10.1093/protein/10.1.1 · Cited by 5,356
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Role of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
Self-citationNakai, K., & Horton, P. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01336-x · Cited by 2,181 · cited 1×
“A notable feature of the deduced amino-acid sequence of resistin is a hydrophobic amino terminus that is predicted by the Prosor”
BackgroundmPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Cited by
Items 501–600 of 1,052
A Promoter Genotype and Oxidative Stress Potentially Link Resistin to Human Insulin Resistance
Smith, S. R., Bai, F., Charbonneau, C., Janderová, L., & Argyropoulos, G. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1611 · Cited by 188
Sleep and the metabolic syndrome
Wolk, R., & Somers, V. K. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2006.033787 · Cited by 187
Nutritional effects on T‐cell immunometabolism
Cohen, S., Danzaki, K., & MacIver, N. J. (2017) · European Journal of Immunology · doi:10.1002/eji.201646423 · Cited by 187
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
Zhao, B., Wall, R. J., & Yang, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.044 · Cited by 186
Anderson, H. D. I., Rahmutula, D., & Gardner, D. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309552200 · Cited by 186
11β-hydroxysteroid dehydrogenases: changing glucocorticoid action
Seckl, J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.001 · Cited by 185
Review article: adipocytokines and insulin resistance
VETTOR, R., MILAN, G., ROSSATO, M., & FEDERSPIL, G. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02587.x · Cited by 185
Yang, Z.-H., Miyahara, H., Takeo, J., & Katayama, M. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-32 · Cited by 185
Giorgio, V., Prono, F., Graziano, F., & Nobili, V. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-40 · Cited by 185
Adipose Tissue and Metabolic Health
An, S.-M., Cho, S.-H., & Yoon, J. C. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0011 · Cited by 184
Impairment of Insulin Signaling in Human Skeletal Muscle Cells by Co-Culture With Human Adipocytes
Dietze, D., Koenen, M., Röhrig, K., Horikoshi, H., Hauner, H., & Eckel, J. (2002) · Diabetes · doi:10.2337/diabetes.51.8.2369 · Cited by 183
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Zhang, Y., Sun, X., Icli, B., & Feinberg, M. W. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1122 · Cited by 183
Haugen, F., Ranheim, T., Harsem, N. K., Lips, E., Staff, A. C., & Drevon, C. A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00020.2005 · Cited by 183
Haluzik, M., Colombo, C., Gavrilova, O., Chua, S., Wolf, N., Chen, M., Stannard, B., Dietz, K. R., Le Roith, D., & Reitman, M. L. (2004) · Endocrinology · doi:10.1210/en.2004-0219 · Cited by 182
Fatty acids and insulin resistance in muscle and liver
Kovacs, P. L., & Stümvoll, M. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.003 · Cited by 182
Ghosh, S., Singh, A., Battu, A., Mukhopadhyay, S., & Ehtesham, N. Z. (2003) · Gene · doi:10.1016/s0378-1119(02)01213-1 · Cited by 181
Ethnicity, type 2 diabetes & migrant Asian Indians.
Abate, N., & Chandalia, M. (2007) · PubMed · Cited by 183
Vaspin: a novel serpin with insulin-sensitizing effects
Wada, J. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.3.327 · Cited by 180
Fat poetry: a kingdom for PPARγ
Anghel, S. I., & Wahli, W. (2007) · Cell Research · doi:10.1038/cr.2007.48 · Cited by 186
The Metabolic Syndrome: Peroxisome Proliferator-Activated Receptor γ and Its Therapeutic Modulation
Gurnell, M., Savage, D. B., Chatterjee, V. K. K., & O’Rahilly, S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030435 · Cited by 179
FIZZ1 Stimulation of Myofibroblast Differentiation
Liu, T., Dhanasekaran, S. M., Jin, H., Hu, B., Tomlins, S. A., Chinnaiyan, A. M., & Phan, S. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63218-x · Cited by 179
Peptidomics technologies for human body fluids
Schrader, M., & Schulz-Knappe, P. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(01)00010-5 · Cited by 179
Prakash, O., Hossain, F. M., Danos, D., Lassak, A., Scribner, R. A., & Miele, L. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.576964 · Cited by 179
Peroxisome proliferator activated receptors and obesity
Kersten, S. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01431-0 · Cited by 179
Circadian metabolism in the light of evolution
Gerhart-Hines, Z., & Lazar, M. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1007 · Cited by 178
Self-citationPPARγ regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1
Chui, P. C., Guan, H.-P., Lehrke, M., & Lazar, M. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24130 · Cited by 178
Self-citationNonclassic Endogenous Novel Regulators of Angiogenesis
Ribatti, D., Conconi, M. T., & Nussdorfer, G. G. (2007) · Pharmacological Reviews · doi:10.1124/pr.59.2.3 · Cited by 178
Obesity, Adipokines, and Abdominal Aortic Aneurysm: Health in Men Study
Golledge, J., Clancy, P., Jamrozik, K., & Norman, P. E. (2007) · Circulation · doi:10.1161/circulationaha.107.717926 · Cited by 178
Eckardt, K., Taube, A., & Eckel, J. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9168-2 · Cited by 181
Central Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor 4
Benomar, Y., Gertler, A., De Lacy, P., Crépin, D., Ould Hamouda, H., Riffault, L., & Taouis, M. (2013) · Diabetes · doi:10.2337/db12-0237 · Cited by 177
Lee, M.-W., Lee, M., & Oh, K.-J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8060854 · Cited by 177
Nagaev, I., Bokarewa, M., Tarkowski, A., & Smith, U. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000031 · Cited by 177
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
Becker, S., Dossus, L., & Kaaks, R. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902878054 · Cited by 177
Chung, C., Long, A., Solus, J., Rho, Y., Oeser, A., Raggi, P., & Stein, C. (2009) · Lupus · doi:10.1177/0961203309103582 · Cited by 177
Obesity, Peroxisome Proliferator-Activated Receptor, and Atherosclerosis in Type 2 Diabetes
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000191663.12164.77 · Cited by 176
Ramteke, P. L., Deb, A., Shepal, V., & Bhat, M. K. (2019) · Cancers · doi:10.3390/cancers11091402 · Cited by 176
Resistin as an Intrahepatic Cytokine
Bertolani, C., Sancho‐Bru, P., Failli, P., Bataller, R. A., Aleffi, S., DeFranco, R., Mazzinghi, B., Romagnani, P., Milani, S., Ginès, P., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060081 · Cited by 176
Farvid, M. S., Ng, T., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00410.x · Cited by 176
Guan, Y. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139067.83419.46 · Cited by 175
Moon, B. C., Kwan, J. J., Duddy, N., Sweeney, G., & Begum, N. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00457.2002 · Cited by 175
Taxvig, C., Dreisig, K., Boberg, J., Nellemann, C., Schelde, A. B., Pedersen, D., Boergesen, M., Mandrup, S., & Vinggaard, A. M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.021 · Cited by 174
Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans
Utzschneider, K. M., Carr, D. B., Tong, J., Wallace, T. M., Hull, R. L., Zraika, S., Xiao, Q., Mistry, J. S., Retzlaff, B. M., Knopp, R. H., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1932-y · Cited by 174
Higami, Y., Pugh, T. D., Page, G. P., Allison, D. B., Prolla, T. A., & Weindruch, R. (2004) · The FASEB Journal · doi:10.1096/fj.03-0678fje · Cited by 173
“Recently, several white adipose tissue (WAT)-derived secretory molecules such as leptin (35), tumor necrosis factor (TNF)-α (6, 7), adiponectin (4, 8), and resistin (9) have been characterized, and some of these molecules are involved in obesity and insulin resistance.”
BackgroundThe Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction
Packer, M. (2025) · JACC · doi:10.1016/j.jacc.2025.06.055 · Cited by 173
Inflammation and NF-κB in Alzheimer's Disease and Diabetes
Granic, I., Dolga, A. M., Nijholt, I. M., van Dijk, G., & Eisel, U. L. M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0976 · Cited by 173
Insulin Resistance and Hyperglycemia in Critical Illness: Role of Insulin in Glycemic Control
Robinson, L. E., & van Soeren, M. H. (2004) · AACN Clinical Issues: Advanced Practice in Acute and Critical Care · doi:10.1097/00044067-200401000-00004 · Cited by 173
Hugh, J. M., Voorhees, A. S. V., Nijhawan, R. I., Bagel, J., Lebwohl, M., Blauvelt, A., Hsu, S., & Weinberg, J. M. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.09.020 · Cited by 173
Roche, J. R., Blache, D., Kay, J. K., Miller, D. R., Sheahan, A. J., & Miller, D. W. (2008) · Nutrition Research Reviews · doi:10.1017/s0954422408138744 · Cited by 179
Intramyocellular lipids and insulin resistance
Machann, J., Häring, H., Schick, F., & Stumvoll, M. (2004) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.00339.x · Cited by 172
Teng, X., Li, D., Champion, H. C., & Johns, R. A. (2003) · Circulation Research · doi:10.1161/01.res.0000073999.07698.33 · Cited by 172
Management of Type 2 Diabetes: Current Strategies, Unfocussed Aspects, Challenges, and Alternatives
Borse, S., Chhipa, A. S., Sharma, V., Singh, D. P., & Nivsarkar, M. (2020) · Medical Principles and Practice · doi:10.1159/000511002 · Cited by 172
Resistin: molecular history and prognosis
Banerjee, R. R., & Lazar, M. A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0428-9 · Cited by 172
Self-citationSmitka, K., & Marešová, D. (2015) · Prague Medical Report · doi:10.14712/23362936.2015.49 · Cited by 171
Adiponectin and energy homeostasis
Lee, B., & Shao, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9283-3 · Cited by 171
Gordura visceral, subcutânea ou intramuscular: onde está o problema?
Hermsdorff, H. H. M., & Monteiro, J. B. R. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000600005 · Cited by 171
The Related Metabolic Diseases and Treatments of Obesity
Yang, M., Liu, S., & Zhang, C. (2022) · Healthcare · doi:10.3390/healthcare10091616 · Cited by 170
Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics
Torres, S., Fabersani, E., Marquez, A., & Gauffin-Cano, P. (2019) · European Journal of Nutrition · doi:10.1007/s00394-018-1790-2 · Cited by 170
PATHOGENESIS OF TYPE 2 DIABETES
Boden, G. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70216-4 · Cited by 169
Di Marzio, D. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s993 · Cited by 169
Landreth, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00296-2 · Cited by 169
5′ Flanking Variants of Resistin Are Associated With Obesity
Engert, J. C., Vohl, M.-C., Williams, S. M., Lepage, P., Loredo-Osti, J. C., Faith, J., Doré, C., Renaud, Y., Burtt, N. P., Villeneuve, A., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1629 · Cited by 169
Obesity, adipokines and neuroinflammation
Aguilar-Valles, A., Inoue, W., Rummel, C., & Luheshi, G. N. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.023 · Cited by 168
Prevention of Diabetes and Cardiovascular Disease in Obesity
La Sala, L., & Pontiroli, A. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218178 · Cited by 168
Expression of adiponectin and its receptors in swine1,2
Lord, E., Ledoux, S., Murphy, B. D., Beaudry, D., & Palin, M. F. (2005) · Journal of Animal Science · doi:10.2527/2005.833565x · Cited by 168
Peroxisome Proliferator-Activated Receptor γ Induces a Clearance Mechanism for the Amyloid-β Peptide
Camacho, I. E., Serneels, L., Spittaels, K., Merchiers, P., Dominguez, D., & De Strooper, B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3987-04.2004 · Cited by 168
Koch, A., Gressner, O. A., Sanson, E., Tacke, F., & Trautwein, C. (2009) · Critical Care · doi:10.1186/cc7925 · Cited by 168
Zhu, M., Miura, J., Lu, L. X., Bernier, M., DeCabo, R., Lane, M. A., Roth, G. S., & Ingram, D. K. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.03.024 · Cited by 168
Effects of Obesity Surgery on Non–Insulin-Dependent Diabetes Mellitus
Greenway, S. E. (2002) · Archives of Surgery · doi:10.1001/archsurg.137.10.1109 · Cited by 168
Gavi, S., Stuart, L. M., Kelly, P., Melendez, M. M., Mynarcik, D. C., Gelato, M. C., & McNurlan, M. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1815 · Cited by 168
Ruiz‐Fernández, C., Francisco, V., Pino, J., Mera, A., González-Gay, M. Á., Gómez, R., Lago, F., & Gualillo, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20082030 · Cited by 169
Lipids and Glucose in Type 2 Diabetes
Boden, G., & Laakso, M. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2253 · Cited by 167
Role of Leptin in Pregnancy—A Review
Sagawa, N., Yura, S., Itoh, H., Mise, H., Kakui, K., Korita, D., Takemura, M., Nuamah, M. A., Ogawa, Y., Masuzaki, H., et al. (2002) · Placenta · doi:10.1053/plac.2002.0814 · Cited by 167
The relationship between gut and adipose hormones, and reproduction
Comninos, A. N., Jayasena, C. N., & Dhillo, W. S. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmt033 · Cited by 167
Wnt10b Inhibits Obesity in ob/ob and Agouti Mice
Wright, W. S., Longo, K. A., Dolinsky, V. W., Gerin, I., Kang, S., Bennett, C. N., Chiang, S.-H., Prestwich, T. C., Gress, C., Burant, C. F., et al. (2007) · Diabetes · doi:10.2337/db06-1339 · Cited by 167
Propheter, D. C., Chara, A. L., Harris, T. A., Ruhn, K. A., & Hooper, L. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711395114 · Cited by 167
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Boutari, C., Perakakis, N., & Mantzoros, C. S. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.1.33 · Cited by 167
Lay, S. L., Lefrère, I., Trautwein, C., Dugail, I., & Krief, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203913200 · Cited by 167
Liu, T., Jin, H., Ullenbruch, M., Hu, B., Hashimoto, N., Moore, B., McKenzie, A., Lukacs, N. W., & Phan, S. H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3425 · Cited by 167
Intrauterine growth restriction and adult disease: the role of adipocytokines
Briana, D. D., & Malamitsi‐Puchner, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0621 · Cited by 167
Peptidomics technologies for human body fluids
Schrader, M., & Schulz‐Knappe, P. (2001) · Trends in biotechnology · doi:10.1016/s0167-7799(01)01800-5 · Cited by 167
Role of resistin in cardiac contractility and hypertrophy
Kim, M., Oh, J. K., Sakata, S., Liang, I., Park, W., Hajjar, R. J., & Lebeche, D. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.006 · Cited by 167
Nawrocki, A., & Scherer, P. E. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.003 · Cited by 167
Metabolic complications of obesity in childhood and adolescence: more than just diabetes
Nathan, B. M., & Moran, A. (2008) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e3282f43d19 · Cited by 166
Waterman, C., Rojas‐Silva, P., Tumer, T. B., Kuhn, P., Richard, A. J., Wicks, S., Stephens, J. M., Wang, Z., Mynatt, R., Cefalu, W., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400679 · Cited by 166
Uncoupling proteins: their roles in adaptive thermogenesis and substrate metabolism reconsidered
Dulloo, A. G., & Samec, S. (2001) · British Journal of Nutrition · doi:10.1079/bjn2001412 · Cited by 166
Increased visfatin concentrations in women with gestational diabetes mellitus
Krzyzanowska, K., Krugluger, W., Mittermayer, F., Rahman, R., Haider, D., Shnawa, N., & Schernthaner, G. (2006) · Clinical Science · doi:10.1042/cs20050363 · Cited by 166
Šenolt, L., Pavelká, K., Housa, D., & Haluzík, M. (2006) · Cytokine · doi:10.1016/j.cyto.2006.09.002 · Cited by 166
Molecular determinants of brown adipocyte formation and function: Figure 1.
Farmer, S. R. (2008) · Genes & Development · doi:10.1101/gad.1681308 · Cited by 165
Adipokines, Metabolic Syndrome and Rheumatic Diseases
Abella, V., Scotece, M., Conde, J., López, V., Lazzaro, V., Pino, J., Gómez-Reino, J. J., & Gualillo, O. (2014) · Journal of Immunology Research · doi:10.1155/2014/343746 · Cited by 165
Adipocytokines and liver disease
Kamada, Y., Takehara, T., & Hayashi, N. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2213-6 · Cited by 165
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 167
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170042 · Cited by 164
Mood Disorders and Obesity: Understanding Inflammation as a Pathophysiological Nexus
Soczynska, J. K., Kennedy, S. H., Woldeyohannes, H. O., Liauw, S. S., Alsuwaidan, M., Yim, C. Y., & McIntyre, R. S. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8140-8 · Cited by 164
Cytokines in the Progression of Pancreatic β-Cell Dysfunction
Wang, C., Guan, Y., & Yang, J. (2010) · International Journal of Endocrinology · doi:10.1155/2010/515136 · Cited by 164
Kumari, R., Kumar, S., & Kant, R. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.06.005 · Cited by 167
Morton, N. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163
Coccurello, R., & Moles, A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.008 · Cited by 163
Resistin: Insulin resistance to malignancy
Codoñer‐Franch, P., & Alonso‐Iglesias, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.043 · Cited by 163
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 163
Ectopic fat accumulation and metabolic syndrome
Rasouli, N., Molavi, B., Elbein, S. C., & Kern, P. A. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00590.x · Cited by 162
Metadata
- Authors
- Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A.
- Affiliations
- University of Pennsylvania Health System (US)
- University of Pennsylvania (US)
- Corresponding author
- Lazar, Mitchell A.
- Venue
- Nature
- Published
- 2001-01
- Volume
- 409
- Issue
- 6818
- Pages
- 307-312
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1675830194
- Cited by
- 4,755
- References
- 37
- Citations by year
- 2026: 59 · 2025: 77 · 2024: 108 · 2023: 128 · 2022: 152 · 2021: 147 · 2020: 140 · 2019: 160 · 2018: 137 · 2017: 187 · 2016: 175 · 2015: 197 · 2014: 239 · 2013: 243 · 2012: 217
- FWCI
- 184.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- resistin, obesity, type 2 diabetes, insulin resistance, adipocytes, adipokines, rosiglitazone, glucose tolerance, insulin-stimulated glucose uptake, diet-induced obesity, genetic obesity
- MeSH terms
- Rosiglitazone, Amino Acid Sequence, Animals, Base Sequence, Chromosomes, Human, Pair 19, Cloning, Molecular, Diabetes Mellitus, Diabetes Mellitus, Type 2, Diet, DNA, Female, Gene Expression Regulation, Hormones, Hormones, Ectopic, Humans, Hypoglycemic Agents, Insulin Antagonists, Insulin Resistance, Male, Mice, Inbred C57BL, Molecular Sequence Data, Neutralization Tests, Obesity, Proteins, Thiazoles, Signal Transduction, 3T3 Cells, Adipocytes, Glucose Intolerance, Nerve Growth Factor, Intercellular Signaling Peptides and Proteins, Thiazolidinediones, Mice, Resistin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.